These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12712238)

  • 1. In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non-human primates.
    Bîrsan T; Dambrin C; Klupp J; Stalder M; Larson MJ; Fitzsimmons WE; Morris RE
    Transpl Int; 2003 May; 16(5):354-60. PubMed ID: 12712238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the malononitrilamide FK778 on immune functions in vitro in whole blood from non-human primates and healthy human volunteers.
    Bîrsan T; Dambrin C; Klupp J; Stalder M; Fitzsimmons WE; Morris RE
    Transpl Immunol; 2003; 11(2):163-7. PubMed ID: 12799199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel immunosuppressant FK778 inhibits formation of the immunologic Synapse.
    Zeyda M; Geyeregger R; Poglitsch M; Watschinger B; Hörl WH; Stulnig TM; Säemann MD
    Transplant Proc; 2005 May; 37(4):1970-1. PubMed ID: 15919521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
    Qi S; Zhu S; Xu D; Wang X; Ouyang J; Jiang W; Vu MD; Bilolo K; Ma A; Johnson S; Daloze P; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Apr; 75(8):1124-8. PubMed ID: 12717189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK778: new cellular and molecular mechanisms of action.
    Schrepfer S; Deuse T; Koch-Nolte F; Detter C; Reichenspurner H
    Transplant Proc; 2006 Apr; 38(3):757-61. PubMed ID: 16647464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2005 Dr. Gary J. Becker Young Investigator Award: periprocedural oral administration of the leflunomide analogue FK778 inhibits neointima formation in a double-injury rat model of restenosis.
    Jahnke T; Schäfer FK; Bolte H; Rector L; Schäfer PJ; Brossmann J; Fändrich F; Hedderich J; Heller M; Müller-Hülsbeck S
    J Vasc Interv Radiol; 2005 Jul; 16(7):903-10. PubMed ID: 16002499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    Schrepfer S; Deuse T; Koch-Nolte F; Krieger T; Haddad M; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    J Heart Lung Transplant; 2007 Jan; 26(1):70-7. PubMed ID: 17234520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
    Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schwedhelm E; Böger R; Schäfer H; Detter C; Reichenspurner H
    J Heart Lung Transplant; 2005 Nov; 24(11):1844-54. PubMed ID: 16297791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide derivative FK778 inhibits production of antibodies in an experimental model of alloreactive T-B cell interaction.
    Ramos-Barrón MA; Gómez-Alamillo C; Santiuste I; Agüeros C; Cosme LS; Benito A; Gimenez T; Merino J; Merino R; Arias M
    Exp Clin Transplant; 2009 Dec; 7(4):218-24. PubMed ID: 20353370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The malononitrilamide FK778 inhibits activation of NF-kappaB in human dendritic cells.
    Zeyda M; Stuhlmeier KM; Kirsch B; Watschinger B; Hörl WH; Stulnig TM; Säemann MD
    Transplant Proc; 2005 May; 37(4):1968-9. PubMed ID: 15919520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy.
    Stalder M; Bîrsan T; Hausen B; Borie DC; Morris RE
    Transpl Int; 2005 Oct; 18(10):1158-65. PubMed ID: 16162103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    Schrepfer S; Deuse T; Sultan KR; Haddad M; Böger R; Münzel T; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    Cardiology; 2007; 108(2):128-37. PubMed ID: 17028423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.
    Zonta S; Alessiani M; Viganò J; Doni M; Bardone M; Dominioni T; De Martino M; Scaglione M; Vicini E; Filisetti C; Biroli A; Bottazzi A; Villa C; Morbini P; Dionigi P
    Transplant Proc; 2007; 39(6):2021-3. PubMed ID: 17692681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs.
    Jin MB; Nakayama M; Ogata T; Fujita M; Mino K; Taniguchi M; Suzuki T; Shimamura T; Furukawa H; Todo S
    Surgery; 2002 Jul; 132(1):72-9. PubMed ID: 12110798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.